Labshake search
Citations for R&D Systems :
2851 - 2900 of 3633 citations for Human Ras Related Protein M Ras MRAS ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: Recombinant Mouse IL-15R alpha Fc Chimera Protein (R&D Systems) and recombinant Mouse IL-15 (Tonbo Biosciences ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant mouse IL-15Ralpha Fc chimera protein (R&D Systems), in RPMI medium (Corning Life Sciences ...
-
bioRxiv - Bioengineering 2024Quote: ... and CD52 protein for alemtuzumab were purchased from R&D systems, and recombinant human CD20 for rituximab ...
-
bioRxiv - Developmental Biology 2023Quote: ... recombinant mNope-ECD-Fc protein (Biotechne/R&D Systems, 1294-NP) was added at 25 μg/ml (≍ 0.2 μM ...
-
bioRxiv - Bioengineering 2023Quote: ... The following recombinant target proteins were purchased from R&D Systems: CRP (1707-CR) ...
-
bioRxiv - Immunology 2023Quote: ... Proteins were detected using Rat anti-IL-33 (R&D Systems) and Rabbit β-Actin (Cell Signaling Technology ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Cancer Biology 2023Quote: ... The following proteins were analyzed: TGF-β (FCSTM17, R&D Systems), CCL2 and TNF (HCYTOMAG ...
-
bioRxiv - Neuroscience 2023Quote: ... Plasma levels of C-reactive protein (CRP) (R&D systems, DY1829), vascular cell adhesion molecule 1 (VCAM-1 ...
-
bioRxiv - Developmental Biology 2023Quote: ... Stock recombinant zebrafish BMP4 protein (R&D Systems 1128-BM-010) was reconstituted to 20 µg/mL in 0.1% bovine serum albumin (BSA ...
-
bioRxiv - Microbiology 2023Quote: ... 200ng of recombinant ANXA2 protein (Cat# 9409-AN, R&D Systems) diluted in PBS ...
-
bioRxiv - Immunology 2023Quote: ... the non-adherent fraction was seeded at 106 cells/well in 24-well plates in medium containing 30ng/ml M-CSF and 10ng/ml RANKL (R&D Systems, Cat. 452-TEC-019). The medium was replaced with supplemented M-CSF and RANKL after 48hr ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the medium was changed to α-MEM containing 20 ng/ml M-CSF and 20 ng/ml RANKL (462-TEC; R&D Systems, Minneapolis, MN, USA). The differentiation medium was changed every 24 hr during the 5-day differentiation period.
-
bioRxiv - Developmental Biology 2024Quote: ... for 5 days followed by a further 15 days in Stage 2b media (HCM containing 10 𝜇g/mL Oncostatin M (R&D Systems Cat No. 295-OM) and 10nM dexamethasone).
-
bioRxiv - Immunology 2021Quote: ... the membrane was incubated with mouse anti-human IL-22 antibody (1 μg/ml; R&D systems, USA) overnight at 4°C ...
-
bioRxiv - Developmental Biology 2020Quote: ... hiPSCs were incubated with the primary antibody goat anti-human OCT3/4 (R&D Systems, Minneapolis, MN, USA), mouse anti-human SOX2 (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Immunology 2019Quote: ... Following an overnight culture islets were treated with 200 U/ml recombinant human (h) TNFα (R&D Systems) for 1 ...
-
bioRxiv - Immunology 2019Quote: ... and antibodies were obtained as follows: recombinant human VCAM-1 (#862-VC) from R&D Systems (Minneapolis, MN); recombinant human IL-2 from the NIH AIDS Reagent Program ...
-
bioRxiv - Genomics 2021Quote: ... medium supplemented with 100ng/mL recombinant human/mouse/rat activin A (R&D systems, cat. 338-AC-010) and incubated cells for 18 hours ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were treated for 1h at 37°C with 5nM of human SEMA3A Fc chimera (R&D System), dissolved in 1x Dulbecco’s PBS (DPBS ...
-
bioRxiv - Cancer Biology 2019Quote: ... human IFN-β blocking antibody (Clone AF814; R&D) and its corresponding isotype (Goat IgG, R&D Systems) were used at a concentration of 0.2 µg/ml ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human PRDX6 (150 μg/mL final) and active MAPK (ERK2, R&D Systems, 10 μg/mL final) were added to 30 μL of a phosphorylation buffer containing 50 mM Tris/HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2022Quote: ... Microvessels with and without 24 h treatment with 5 ng mL-1 human recombinant TNFα (R&D Systems), were perfused with THP1s under low shear stress (∼0.2 dyne cm-2 ...
-
bioRxiv - Immunology 2022Quote: ... were coated at 4°C overnight with a mouse anti-human IL7R monoclonal antibody (R&D Systems, # MAB306). The next day ...
-
bioRxiv - Bioengineering 2022Quote: ... media in the top compartment was replaced with recombinant human TNFα (0.1 ng/mL, R&D Systems, 210TA) and recombinant human IFNγ (2 IU/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... the beads were introduced to either 20 nM recombinant human GAS6 (R&D Systems, Cat# 885-GSB-050), or recombinant human Protein S (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... then incubated with various concentrations (0 to 100 nM) of human recombinant tau (2N4R, R&D Systems Inc.) in the absence or presence of RAP (at a 20-fold molar excess compared to the concentration of tau ...
-
bioRxiv - Genomics 2019Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells were incubated for 8 hours prior to harvest ...
-
bioRxiv - Cell Biology 2022Quote: ... or Basal Medium plus 100 ng/ml recombinant human NTN1 (6419-N1, R&D Systems, Minneapolis, MI, USA). Photographs were taken after 4 h of incubation ...
-
bioRxiv - Biochemistry 2019Quote: ... These wells were suspended above wells containing 5 to 10 ng/mL recombinant human VEGF (R&D Systems) or full serum medium ...
-
bioRxiv - Cell Biology 2019Quote: ... Control medium was then augmented with 10 ng/mL recombinant human TGF-β1 (R&D Systems; chondrogenic media) to induce chondrogenesis ...
-
bioRxiv - Immunology 2019Quote: ... the slides were incubated with a mouse anti-human TGF-β1 antibody (Cat No. MAB240, R&D Systems) at a dilution of 1:50 overnight ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Cancer Biology 2019Quote: The phosphorylation of signaling mediators was analyzed using the Human Phospho-MAPK Antibody Array (#ARY002B, R&D Systems) according to the manufacturer’s protocol ...
-
bioRxiv - Biochemistry 2021Quote: Chemotaxis assays were performed using Transwells (6.5mm diameter insert, 5.0μm pore size, Costar) coated with human ICAM-1 (5μg/ml, R&D systems). Transfected Jurkat T cells (1 × 106 cells/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... 200 U/ml recombinant murine GM-CSF and 10 ng/ml recombinant human TGFβ (R&D Systems, USA). Partial medium change was performed at day 3 of differentiation ...
-
bioRxiv - Immunology 2020Quote: ... The mouse anti-human MSR1 (Cat# MAB2708) antibody was obtained from R&D Systems (Minneapolis, MN 55413, USA). Then rabbit anti-VSV-G (Cat#V4888 ...
-
bioRxiv - Genomics 2020Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells incubated for 8 hours prior to harvest.
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Pathology 2024Quote: ... Cells were then incubated for 1 h at 37°C with mouse anti-human PECAM1 (R&D Systems), which was diluted 1:1000 in 1% BSA/PBS using 300 μl/well ...
-
bioRxiv - Developmental Biology 2024Quote: ... we pre-treated 1 mL of FBS with 2.5 mg of recombinant human ALK1-Fc (R&D systems) and rocked at room temperature for 2 hours before adding to 49 mL EGM2 for a final concentration of 50 µg/mL ALK1-Fc ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant BMP-4 (R&D Systems) and 20 ng/mL human recombinant FGF-4 (R&D Systems) ...
-
bioRxiv - Molecular Biology 2023Quote: Control and Slc7a7-/- mice were intraperitoneally injected with recombinant human erythropoietin (500 U/kg/day; R&D Systems) daily for three consecutive days ...
-
bioRxiv - Immunology 2023Quote: Multiple human and mouse cytokines were analysed using Proteome Profiler Antibody Arrays (R&D Systems, ARY005 and ARY006). The kit membranes were incubated with culture media from human fibroblasts and mouse astrocytes infected with SeV or mock infected in accordance with the manufacturer’s instructions.
-
bioRxiv - Cell Biology 2023Quote: ... EBs were formed in an ESC medium depleted of recombinant human FGF-2 (rhFGF-2) (R&D Systems) on day 0 ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were treated for 24h with 100ng/ml media of human recombinant GBA (rhGBA-His (R&D Systems)).
-
bioRxiv - Cancer Biology 2023Quote: ... C2C12 cells were treated with ZA in the presence or absence of recombinant human TGFβ1 (R&D Systems).
-
bioRxiv - Neuroscience 2023Quote: ... Supernatants were collected and analyzed using the Proteome Profiler Array Human Cytokine Array (R&D Systems catalog # ARY005B) following the manufacturer’s instructions ...